ID

28840

Description

Study ID: 100723 Clinical Study ID: AXR100723 Study Title: A 24 Week Randomized, Double-blind, Double-dummy, Multicenter Study to Compare the Efficacy of Formulation X and AVANDIA™ (8mg OD) in Subjects with Type 2 Diabetes Mellitus Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: rosiglitazone Trade Name: Avandia; Avandia XR; Avandia XR,Rosiglitazone XR,Avandia; Rosiglitazone XR Study Indication: Diabetes Mellitus, Type 2 Documentation part: Baseline/Randomisation - Visit 4

Mots-clés

Versions (1)
  1. 08/02/2018 08/02/2018 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

8 février 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Efficacy of Formulation X and AVANDIA in Subjects with Type 2 Diabetes Mellitus 100723

Anglais

Baseline/Randomisation - Visit 4

1 Formulaires  
Adverse Events
Description

Adverse Events

Alias
UMLS CUI-1
C0877248
Center
Description

Center

Type de données

text

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C0600091
Subject ID
Description

Subject ID

Type de données

text

Alias
UMLS CUI [1]
C2348585
Initials
Description

Initials

Type de données

text

Alias
UMLS CUI [1]
C2986440
Visit Date
Description

Visit Date

Type de données

date

Alias
UMLS CUI [1]
C1320303
Are there any new adverse events/ serious adverse events observed or reported by the subject or any changes to ongoing adverse events?
Description

I f 'Yes', record details on the Adverse Events panel.

Type de données

boolean

Alias
UMLS CUI [1]
C0877248
Concomitant Medications
Description

Concomitant Medications

Alias
UMLS CUI-1
C2347852
UMLS CUI-2
C0013227
Has there been any changes to the subject's concomitant medication or any new medications taken since the last visit?
Description

If 'Yes', record details on the Concomitant Medications panel.

Type de données

boolean

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C2169461
Vital Signs
Description

Vital Signs

Alias
UMLS CUI-1
C0518766
Weight
Description

Weight

Type de données

float

Unités de mesure
  • kg
Alias
UMLS CUI [1]
C0005910
kg
Blood Pressure - sitting, Systolic
Description

Blood Pressure - sitting, Systolic

Type de données

integer

Unités de mesure
  • mmHg
Alias
UMLS CUI [1,1]
C0871470
UMLS CUI [1,2]
C0277814
mmHg
Blood Pressure - sitting, Diastolic
Description

Blood Pressure - sitting, Diastolic

Type de données

integer

Unités de mesure
  • mmHg
Alias
UMLS CUI [1,1]
C0428883
UMLS CUI [1,2]
C0277814
mmHg
Heart Rate
Description

Heart Rate

Type de données

integer

Unités de mesure
  • beats/min
Alias
UMLS CUI [1]
C0018810
beats/min
Waist circumference
Description

Waist circumference

Type de données

float

Unités de mesure
  • cm
Alias
UMLS CUI [1]
C0455829
cm
Central Laboratory
Description

Central Laboratory

Alias
UMLS CUI-1
C1880016
UMLS CUI-2
C0022885
Were lab samples obtained?
Description

lab samples

Type de données

boolean

Alias
UMLS CUI [1]
C0005834
UMLS CUI [2]
C0200354
Date Sample Taken
Description

Date Sample Taken

Type de données

date

Alias
UMLS CUI [1]
C1302413
Investigational Product Compliance
Description

Investigational Product Compliance

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C1321605
What is your assessment of the subject's investigational product compliance (in % ) since the last visit?
Description

Investigational Product Compliance

Type de données

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1321605
I f compliance is < 80% or > 120% , check the box next to any reason(s) below that apply.
Description

Investigational Product Compliance Reason

Type de données

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1321605
UMLS CUI [1,3]
C0392360
If other reason, please specify
Description

Investigational Product Compliance Reason

Type de données

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1321605
UMLS CUI [1,3]
C0392360
Subject Continuation
Description

Subject Continuation

Alias
UMLS CUI-1
C0805733
UMLS CUI-2
C2348568
Is the subject continuing in the study?
Description

If 'No', complete the Study Conclusion panel.

Type de données

boolean

Alias
UMLS CUI [1]
C0805733
Randomisation Number
Description

Randomisation Number

Alias
UMLS CUI-1
C0034656
UMLS CUI-2
C0237753
Randomisation Number
Description

Randomisation Number

Type de données

text

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C0237753
Retour au début de la page

Similar models

Baseline/Randomisation - Visit 4

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Adverse Events
C0877248 (UMLS CUI-1)
Center
Item
Center
text
C1301943 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Subject ID
Item
Subject ID
text
C2348585 (UMLS CUI [1])
Initials
Item
Initials
text
C2986440 (UMLS CUI [1])
Visit Date
Item
Visit Date
date
C1320303 (UMLS CUI [1])
adverse events
Item
Are there any new adverse events/ serious adverse events observed or reported by the subject or any changes to ongoing adverse events?
boolean
C0877248 (UMLS CUI [1])
Item Group
Concomitant Medications
C2347852 (UMLS CUI-1)
C0013227 (UMLS CUI-2)
changes concomitant medication
Item
Has there been any changes to the subject's concomitant medication or any new medications taken since the last visit?
boolean
C2347852 (UMLS CUI [1,1])
C2169461 (UMLS CUI [1,2])
Item Group
Vital Signs
C0518766 (UMLS CUI-1)
Weight
Item
Weight
float
C0005910 (UMLS CUI [1])
Blood Pressure - sitting, Systolic
Item
Blood Pressure - sitting, Systolic
integer
C0871470 (UMLS CUI [1,1])
C0277814 (UMLS CUI [1,2])
Blood Pressure - sitting, Diastolic
Item
Blood Pressure - sitting, Diastolic
integer
C0428883 (UMLS CUI [1,1])
C0277814 (UMLS CUI [1,2])
Heart Rate
Item
Heart Rate
integer
C0018810 (UMLS CUI [1])
Waist circumference
Item
Waist circumference
float
C0455829 (UMLS CUI [1])
Item Group
Central Laboratory
C1880016 (UMLS CUI-1)
C0022885 (UMLS CUI-2)
lab samples
Item
Were lab samples obtained?
boolean
C0005834 (UMLS CUI [1])
C0200354 (UMLS CUI [2])
Date Sample Taken
Item
Date Sample Taken
date
C1302413 (UMLS CUI [1])
Item Group
Investigational Product Compliance
C0304229 (UMLS CUI-1)
C1321605 (UMLS CUI-2)
Item
What is your assessment of the subject's investigational product compliance (in % ) since the last visit?
integer
C0304229 (UMLS CUI [1,1])
C1321605 (UMLS CUI [1,2])
Investigational Product Compliance
Code List
What is your assessment of the subject's investigational product compliance (in % ) since the last visit?
CL Item
0% compliant (subject did not take any doses) (1)
CL Item
> 0% and < 80% compliant (subject missed a number of doses) (2)
CL Item
>=80% and <=120% (number of doses taken was within compliance range) (3)
CL Item
> 120% compliant (number of doses taken exceeds compliance limits) (4)
Item
I f compliance is < 80% or > 120% , check the box next to any reason(s) below that apply.
integer
C0304229 (UMLS CUI [1,1])
C1321605 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
inclusion criteria the subject failed
Code List
I f compliance is < 80% or > 120% , check the box next to any reason(s) below that apply.
CL Item
Adverse event (ensure that details are recorded in the Adverse Events panel) (1)
CL Item
Dispensing error (2)
CL Item
Subject did not take medication according to protocol (3)
CL Item
Other (4)
Investigational Product Compliance Reason
Item
If other reason, please specify
text
C0304229 (UMLS CUI [1,1])
C1321605 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
Item Group
Subject Continuation
C0805733 (UMLS CUI-1)
C2348568 (UMLS CUI-2)
subject continuing
Item
Is the subject continuing in the study?
boolean
C0805733 (UMLS CUI [1])
Item Group
Randomisation Number
C0034656 (UMLS CUI-1)
C0237753 (UMLS CUI-2)
Randomisation Number
Item
Randomisation Number
text
C0034656 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial